Decheng Capital Management Iii (Cayman), LLC Atri Cure, Inc. Transaction History

Decheng Capital Management Iii (Cayman), LLC

$181 Million
Q3 2023

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 29, 2023	BUY	$41.12 - $57.73 $1.9 Million - $2.67 Million	46,259 New	46,259 $2.03 Million
Q1 2023 May 10, 2023	BUY	$35.87 - $47.22 $1.66 Million - $2.18 Million	46,259 New	46,259 $1.92 Million

Others Institutions Holding ATRC

# of Institutions

206

Shares Held

49.3M

Call Options Held

111K

Put Options Held

23.8K

Vanguard Group Inc Valley Forge, PA

4.62M
Shares

$161 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.62M
Shares

$161 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

4.2M
Shares

$146 Million
0.03% of portfolio
Champlain Investment Partners, LLC Burlington, VT

2.67M
Shares

$93.2 Million
0.39% of portfolio
Macquarie Group LTD Australia, C3

2M
Shares

$69.6 Million
0.05% of portfolio

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.62B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital Management Iii (Cayman), LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital Management Iii (Cayman), LLC with notifications on news.

Account